AMR historical foresight

What is the issue?

Antimicrobial Resistance (AMR) is a complex policy issue that is gaining prominence at a global level. A landmark United Nations Declaration on AMR was signed in 2016 by 193 countries, recognising the need for global action through the collective effort of many different parties.

AMR is a unique problem, but studying the development of other policy issues that are complex and enduring can provide insights into how to tackle AMR going forward. Lessons from the past can contribute to policy design but are often overlooked.

How are we helping?

RAND Europe, together with the University of Exeter and University of East Anglia, has been commissioned to provide a fresh perspective on AMR by using a historical and comparative approach. The study will seek to understand how AMR has developed as a policy issue over time, looking at climate change and tobacco control for comparison. The study will also examine how historical analysis can be used in future approaches to scenario planning and policy making.

The project will draw on reviews of existing evidence, interviews and futures methods including scenario planning. An important part of the research will involve interactive policy events that bring together historians, policymakers and other stakeholders.

Related Research

  • Abstract image of business technology

    Centre Conducts Futures and Foresight Studies

    Through the Centre for Futures and Foresight Studies (CFFS), RAND Europe uses futures techniques from scenario planning to high-level gaming to horizon-scanning to provide clients with actionable insights across both near- and longer-term time horizons.

  • Biofilm of antibiotic resistant bacteria, closeup view

    Antimicrobial Resistance

    RAND Europe's research has provided evidence to support policy and decision making to address AMR. We have contributed economic expertise to a wide-ranging UK review of the threat posed, evaluated the EU's AMR Action Plan, and advised the development of public health guidelines in the UK.